An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
At consideration in committee in the House of Commons
Private Member’s BillOriginated in the House of Commons
Progress
IntroducedMar 11, 2026
2Passed House
3Passed Senate
4Royal Assent
Sponsor
MP
Marcus Powlowski
Member of Parliament
Thunder Bay—Rainy River
Timeline
Introduced
March 11, 2026
Track it
Get notified
We'll email you each time C-265 advances a stage: first reading, committee, chamber to chamber, Royal Assent.
Double opt-in · one-click unsubscribe · we never share your email.